Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: A causal or casual relationship?

Surgery

Volumn 134, Issue 1, 2003, Pages 41-44

  Piñero, Antonio ^a   Rodríguez, Jose M ^a   Martínez Barba, Enrique ^a   Canteras, Manual ^a   Stiges Serra, Antonia ^a   Parrilla, Pascual ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM ION; KI 67 ANTIGEN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARATHYROID ADENOMA; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; THYROID SCINTISCANNING;

EID: 0041313991     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.158     Document Type: Article

References (28)

1. Freitas JE, Freitas AE. Thyroid and parathyroid imaging. Sem Nucl Med 1994;24:234-5.
2. McBiles M, Lambert AT, Cote MC, Kim SY. Sestamibi parathyroid imaging. Sem Nucl Med 1995;25:221-34
3. Light VL, McHenry CR, Jarjoura D, Sodee DB, Mirou SD. Prospective comparison of dual-phase technetium 99m sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg 1996;62:562-8.
4. McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB Jr. Parathyroid localization with technetium 99 m sestamibi: a prospective evaluation. J Am Coll Surg 1996;183:25-30.
5. Caixas A, Berna LL, Hernández A, Tebar FJ, Madariaga P, Vergazo O, et al. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery 1997;121:535-41.
6. st ed. Philadelphia: WB Saunders Company; 1997. p 341-6.
7. Arici C, Cheah WK, Ituarte PHG, Morita E, Lynch TC, Siperstein AE, et al. Can localization studies be used to direct focused parathyroid operations?. Surgery 2001;129:720-9.
8. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adeuomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium 99m sestamibi (double phase study). J Nucl Med 1992;33:1801-7.
9. Foldes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium 99m pertechnetate and technetium 99m methoxyisobutilisonitrile. Eur J Nucl Med 1993;20:330-3.
10. Bonjer HJ, Braining HA, Valkerna R, Lameris JS, de Herder WW, van der Harst E, et al. Single radionuclide scintigraphy with 99m technetium sestamibi and ultrasonography in hyperparathyroidism. Eur J Surg 1997;163:27-32.
11. Piñero A, Rodríguez JM, Ortiz S, Claver MA, Parrilla P. Influence of thyroid pathology on the results of parathyroid gammagraphy with Tc99m-Sestamibi. Clin Endocrinol 2000;53:655-7.
12. Sandrock D, Merino MJ, Norton AJ, Benton CS, Miller DS, Neumann RD. Light and electron microscopic analyses of parathyroid tumours explain results of T1201-Tc99m parathyroid scintigraphy. Eur J Nucl Med 1989;15:410-6.
13. Consensus Development Conference Panel NIH. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991;114:593-7.
14. Piñero A, Rodriguez JM, Ortiz S, Castells MT, Ballesta J, Bermejo J, et al. Estudio del contenido mitocondrial en adenomas paratiroideos y su correlación con la gammagrafia con Tc99m-Sestamibi. Cirugía Española 1999;66:285-8.
15. O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium 99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313-8.
16. Lee VS, Wilkinson RH, Leight GS Jr, Coogan AC, Coleman RE. Hyperparathyroidism in high risk surgical patients: evaluation with double-phase technetium 99m sestamibi imaging. Radiology 1995;197:627-33.
17. Yamaguchi S, Yachiku S, Hashimoto H, Kaneko S, Nishihara M, Niibori D, et al. Relation between Technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. World J Surg 2002;26:29-34.
18. Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody ki-67. J Immunol 1984;133:1710-5.
19. Kip1 protein. Am J Surg Pathol 1999;23:288-95.
20. Piñero A, Rodriguez JM, Ortiz S, Soria T, Bemejo J, Claver MA, et al. Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg 2000;122:851-5.
21. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutilisonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990;82:1826-38.
22. Piwnica-Worms D, Kronauge JF, Delmon L. Effect of metabolic inhibition on technetimn 9m MIBI in cultured chick myocardial cells. J Nucl Med 1990;31:464-72.
23. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Sem Nucl Med 1991;21:173-81.
24. Crane P, Laliberte R, Hemingway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium 99m sestamibi myocardial retention. Eur J Nucl Med 1993;20:20-5.
25. Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, et al. Association of deceased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 2000;58:1980-6.
26. Tominaga Y, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T, et al. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 iu parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 1999;55:1375-83.
27. Cutrone JA, Yospur LS, Khalkhali I, Tolmos J, Devito A, Diggles L, et al. Immunohistologic assessment of technetium 99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med 1998;39:449-53.
28. Bonazzi G, Cistaro A, Bello M, Bessone M, Tetti M, Villata E, et al. Breast cancer cellular proliferation indexes and 99mTc-sestamibi capture: what correlation?. J Exp Clin Cancer Res 2001;20:91-4.